Condition

Pediatric

ClinicalTrials.gov condition label

Clinical trials4

Recruiting1

Common interventions5

Lead sponsors shown4

Clinical trials

4 shown

Semi-closed Loop Automated Insulin Therapy in the Pediatric Population Aged 2-6 Years With Type 1 Diabetes: Impact on Quality of Life and Glycemic ControlNCT06875167 · 2025-03-17

Safety, Tolerability, and Pharmacokinetics of Lumateperone in Pediatric Patients With Schizophrenia or Schizoaffective DisorderNCT04779177 · 2021-03-12

Metabolic and Genetic Impacts of Energy Drinks in YouthNCT03512496 · 2014-12-01

The Cardiovascular Comorbidity in Children With Chronic Kidney Disease StudyNCT01046448 · 2009-07-01

Common interventions

Acute energy drink - CaffeinDIETARY_SUPPLEMENT1 Acute energy drink - DecafDIETARY_SUPPLEMENT1 Acute energy drink - PlaceboDIETARY_SUPPLEMENT1 Lumateperone 28 mgDRUG1 Lumateperone 42 mgDRUG1

Leading sponsors

Fondation Lenval1 Heidelberg University1 Intra-Cellular Therapies, Inc.1 University of Calgary1

Trial status mix

COMPLETED1

RECRUITING1

UNKNOWN1

WITHDRAWN1

Phase mix

NA1

PHASE11

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.